InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Discover the complete record of transactions filed by BROSHY ERAN, Director. Director active across 2 companies, notably Theravance Biopharma, Inc.. In total, 5 disclosures have been published. Total volume traded: €484k. The latest transaction was filed on 14 May 2026 — Levée d'options. Regulator: SEC (Form 4). The full history is openly available.
Declarations5 total
015,757 shares0
Common Stock
SEC:0001256230-26-000002:0·
015,757 shares0
Common Stock
SEC:0001256230-26-000002·
US$242,11314,000 shares@ US$17.29380.029% mcap100.0% of flow
Ordinary Shares
SEC:0001256230-25-000009·
€242,11314,000 shares@ €17.29380.029% mcap50.0% of flow
Ordinary Shares
SEC:0001256230-25-000009:0·
09,852 shares0
Ordinary Shares
SEC:0001415889-22-004328:0·
5 of 5 declarations
About BROSHY ERAN
Eran Broshy is a Board Member at Theravance Biopharma, Inc. and Certara, Inc. He brings a strategic perspective to the board, contributing to the direction and governance of the companies. His diverse experience enriches discussions and decisions within the board.
